EuroVacc is a non-profit organization dedicated to the development of safe and effective vaccines against HIV and other infectious diseases, through promoting and fostering collaborations with world leading vaccine researchers and developers in both public and private sectors.

EuroVacc’s core activity is to facilitate the development of vaccine candidates through early clinical trials, to enable early identification of the promising vaccine candidates and eliminate candidates unlikely to succeed in the clinic, with the ultimate goal to reduce the development risks and accelerate the advancement of the promising candidates to large clinical trials.